Skip to main content

Chemed Corp (CHE) Stock

Chemed Corp Stock Details, Movements and Public Alerts

Stock Details

Chemed Corp (CHE), a prominent company in the healthcare sector within the medical care facilities industry, is based in USA and primarily trades on the NYSE.Currently, the stock is trading at $434.61. Over the past 52 weeks, it has ranged between $407.86 and $622.21. This places the current price at 69.8% of its 52-week high and 6.6% above its 52-week low. Recent trading volume was recorded at 143,826. The 14-day Relative Strength Index (RSI) stands at 46.19, suggesting neutral conditions. The stock is currently trading below its 50-day moving average of $446.05 by 2.56%. Similarly, it is below its 200-day moving average of $514.97 by 15.60%. The MACD histogram is -0.44, indicating bearish momentum (MACD Line: -1.92, Signal Line: -1.48). There are currently 2 active alerts set for CHE by users.

52-Week Range

$622.21 - $407.86

-30.15% from high · +6.56% from low

Avg Daily Volume

202,218

20-day average

100-day avg: 194,398

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

22.78

Near market average

Forward P/E

17.61

Earnings expected to grow

PEG Ratio

1.76

Reasonably valued

Price to Book

5.37

EV/EBITDA

13.98

EPS (TTM)

$19.08

Price to Sales

2.42

Beta

0.47

Less volatile than market

How is CHE valued relative to its earnings and growth?
Chemed Corp trades at a P/E ratio of 22.78, which is near the market average of approximately 20, suggesting the market views it as fairly valued relative to its earnings. Looking ahead, the forward P/E of 17.61 is lower than the current P/E, indicating analysts expect earnings to grow over the next year. The PEG ratio of 1.76 indicates reasonable value when growth is considered.
What is CHE's risk profile compared to the market?
With a beta of 0.47, Chemed Corp is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 5.37 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

11.00%

Operating Margin

12.00%

EBITDA

$412.00M

Return on Equity

24.10%

Return on Assets

13.00%

Revenue Growth (YoY)

3.10%

Earnings Growth (YoY)

-10.80%

How profitable and efficient is CHE's business model?
Chemed Corp achieves a profit margin of 11.00%, meaning it retains $11.00 from every $100 in revenue after all expenses. This represents a solid margin typical of well-run businesses, showing the company can effectively balance revenue generation with cost control. The operating margin of 12.00% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at 24.10% and ROA at 13.00%, the company generates strong returns on invested capital.
What are CHE's recent growth trends?
Chemed Corp's revenue grew by 3.10% year-over-year, showing steady progress in growing the business. This positive trajectory indicates the company maintains competitive positioning in its markets. Earnings decreased by 10.80% year-over-year, reflecting the bottom-line impact of business performance. These growth metrics should be evaluated against MEDICAL CARE FACILITIES industry averages for proper context.

Dividend Information

Dividend Per Share

$2.10

Dividend Yield

0.49%

Ex-Dividend Date

Aug 11, 2025

Dividend Date

Aug 29, 2025

What dividend income can investors expect from CHE?
Chemed Corp offers a dividend yield of 0.49%, paying $2.10 per share annually. This modest yield below 2% suggests the company prioritizes growth investments over current income. While the dividend provides some return, investors are likely attracted more by capital appreciation potential than income generation. To receive the next dividend, shares must be purchased before the ex-dividend date of Aug 11, 2025.
How reliable is CHE's dividend for long-term investors?
The dividend sustainability can be assessed through the payout ratio - Chemed Corp pays $2.10 per share in dividends against earnings of $19.08 per share, resulting in a payout ratio of 11.01%. This conservative payout below 30% indicates excellent dividend safety with substantial room for future increases. The company retains most earnings for growth while still rewarding shareholders. The next dividend payment is scheduled for Aug 29, 2025.

Company Size & Market

Market Cap

$6.1B

Revenue (TTM)

$2.53B

Revenue/Share (TTM)

$173.17

Shares Outstanding

14.11M

Book Value/Share

$76.31

Asset Type

Common Stock

What is CHE's market capitalization and position?
Chemed Corp has a market capitalization of $6.1B, classifying it as a mid-cap stock ($2B-$10B). Mid-caps often represent companies in their growth phase, offering higher growth potential than large-caps but with more stability than small-caps. They can be attractive takeover targets and may become tomorrow's large-caps. With 14.11M shares outstanding, the company's ownership is relatively concentrated. As a participant in the MEDICAL CARE FACILITIES industry, it competes with other firms in this sector.
How does CHE's price compare to its book value?
Chemed Corp's book value per share is $76.31, while the current stock price is $434.61, resulting in a price-to-book (P/B) ratio of 5.70. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$578.50

33.11% upside potential

Analyst Recommendations

Strong Buy

1

Buy

3

Hold

0

Sell

0

Strong Sell

0

How reliable are analyst predictions for CHE?
4 analysts cover CHE with 100% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $578.50 implies 33.1% upside, but targets are often adjusted to follow price moves rather than predict them.
What is the Wall Street consensus on CHE?
Current analyst recommendations:1 Strong Buy, 3 Buy, 000The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Nov 8, 2025, 04:39 PM

Technical Indicators

RSI (14-day)

46.19

Neutral

50-Day Moving Average

$446.05

-2.56% below MA-50

200-Day Moving Average

$514.97

-15.60% below MA-200

MACD Line

-1.92

MACD Signal

-1.48

MACD Histogram

-0.44

Bearish

What does CHE's RSI value tell investors?
The RSI (Relative Strength Index) for CHE is currently 46.19, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being below the 50-day moving average, this confirms bearish conditions.
How should traders interpret CHE's MACD and moving average crossovers?
MACD analysis shows the MACD line at -1.92 below the signal line at -1.48, with histogram at -0.44. This bearish crossover indicates downward pressure. The 50-day MA ($446.05) is below the 200-day MA ($514.97), forming a death cross pattern that often warns of extended weakness. Price is currently below both MAs, confirming weakness.

Indicators last updated: Nov 9, 2025, 12:38 AM

Active Alerts

Alert Condition
Price rises above
Threshold
$520.00
Created
Nov 8, 2025, 04:39 PM
Alert Condition
Forward P/E falls below
Threshold
17 x
Created
Nov 8, 2025, 04:39 PM

Stay Ahead of the Market with Chemed Corp Alerts

Set up price alerts for Chemed Corp and get notified instantly when the price hits your target. Never miss an important price movement again.